论文部分内容阅读
目的:分析和探讨高通量血液透析和低通量血液透析对慢性肾衰竭尿毒症患者的临床透析效果。方法:选取2013年9月—2015年6月收治的慢性肾衰竭尿毒症患者76例,按照入院编号随机分成高通量血液透析组和低通量血液透析组,高通量血液透析组(38例)进行高通量血液透析,低通量血液透析组(38例)进行低通量血液透析,对比两组患者的临床透析效果。结果:高通量血液透析组患者慢性肾衰竭尿毒症的临床治疗总有效率为92.11%,明显高于低通量血液透析组的68.42%,高通量血液透析组肾功能指标的改善时间和治疗计划实施总时间分别为(22.27±3.16)d、(30.87±3.41)d,明显短于低通量血液透析组的(28.37±3.61)d,(36.18±4.49)d,组间对比差异均有统计学意义(P<0.05)。结论:高通量血液透析方法的应用,能够有效提升慢性肾衰竭尿毒症患者的临床透析效果,具有一定的临床实用价值。
Objective: To analyze and discuss the clinical dialysis effects of high-throughput hemodialysis and low-flux hemodialysis on uremia patients with chronic renal failure. Methods: Seventy-six patients with chronic renal failure and uremia admitted from September 2013 to June 2015 were randomly divided into high-flux hemodialysis group and low-dose hemodialysis group according to admission number. Case) for high-throughput hemodialysis, low-pass hemodialysis group (38 cases) for low-hemodialysis hemodialysis, compared two groups of patients clinical dialysis. Results: The total effective rate of clinical treatment of chronic renal failure uremia in high-throughput hemodialysis patients was 92.11%, which was significantly higher than 68.42% in low-dose hemodialysis patients and improvement of renal function in high-throughput hemodialysis patients and The total duration of treatment was (22.27 ± 3.16) days and (30.87 ± 3.41) days, respectively, which was significantly shorter than that in low-dose hemodialysis group (28.37 ± 3.61 days and 36.18 ± 4.49 days, respectively) There was statistical significance (P <0.05). Conclusion: The application of high-throughput hemodialysis can effectively improve the clinical dialysis effect of uremia patients with chronic renal failure, and has certain clinical practical value.